01-10-2016 | Case report
Levofloxacin/rituximab
Acute generalised exanthematous pustulosis (first report with rituximab): case report
Published in: Reactions Weekly | Issue 1/2016
Login to get accessExcerpt
Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
-
* death
-
* life-threatening
-
* hospitalisation
-
* disability
-
* congenital anomaly
-
* requires intervention to prevent permanent impairment or damage